期刊
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
卷 26, 期 7, 页码 1179-1187出版社
SPRINGER JAPAN KK
DOI: 10.1007/s10147-021-01889-w
关键词
PEG; Head and neck cancer; Chemoradiotherapy
类别
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japan
Prophylactic PEG is effective for patients treated with definitive CCRT, especially for those with PS2 or oropharyngeal cancer. The PEG tube use group showed more favorable outcomes in various aspects, but oral intake remains the preferred option.
Background We investigated whether prophylactic percutaneous endoscopic gastrostomy (PEG) is used effectively for patients treated with definitive concurrent chemoradiotherapy (CCRT) and the predictors of the need for PEG. Methods 326 patients with laryngeal, oropharyngeal or hypopharyngeal cancers were retrospectively reviewed. Results The PEG tube use group had more favorable results than the total parenteral nutrition and nasogastric tube groups in terms of rate of serum albumin loss, incidence of severe fever and aspiration pneumonia, CCRT completion rate and hospitalization period. However, it was inferior to oral intake. Analysis of the relative risk of requiring enteral or parenteral nutrition revealed that performance status (PS) 2, primary site (supraglottis, oropharynx, or hypopharynx), N3 disease, and cisplatin were predictors of the need for nutritional support. Conclusions Prophylactic PEG is effective for patients treated with definitive CCRT and is especially required for patients with PS2 or oropharyngeal cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据